Metabolic and pharmacological properties of rutin, a dietary quercetin glycoside, for treatment of inflammatory bowel disease

Pharmaceutical Research

Volumn 22, Issue 9, 2005, Pages 1499-1509

  Kim, Heejung ^a   Kong, Hyesik ^b   Choi, Boim ^a   Yang, Youngwook ^a   Kim, Youngmi ^a   Mi, Jung Lim ^b   Neckers, Len ^b   Jung, Yunjin ^a  

^a Pusan National University   (South Korea)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Inflammatory bowel disease; Nuclear factor kappa B; Quercetin; Quercetin deliverer; Rutin

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; QUERCETIN; RUTOSIDE; SUGAR; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; DEGLYCOSYLATION; DOSE RESPONSE; DRUG EFFECT; DRUG STABILITY; ENTERITIS; EPITHELIUM CELL; GASTROINTESTINAL TRACT; HUMAN; HUMAN CELL; LARGE INTESTINE; MALE; NONHUMAN; PARTITION COEFFICIENT; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE; DIET; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLYCOSYLATION; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINES; MALE; QUERCETIN; RATS; RATS, SPRAGUE-DAWLEY; RUTIN;

EID: 24044511500     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-005-6250-z     Document Type: Article

References (37)

1. R. J. Nijveldt E. van Nood D. E. van Hoorn P. G. Boelens K. van Norren P. A. van Leeuwen 2001 Flavonoids: a review of probable mechanisms of action and potential applications Am. J. Clin. Nutr. 74 4 418 425
2. P. C. Hollman M. B. Katan 1997 Absorption, metabolism and health effects of dietary flavonoids in man Biomed. Pharmacother. 51 8 305 310
3. J. M. Gee I. T. Johnson 2001 Polyphenolic compounds: interactions with the gut and implications for human health Curr. Med. Chem. 8 11 1245 1255
4. C. Fiocchi 1997 Intestinal inflammation: a complex interplay of immune and nonimmune cell interactions Am. J. Physiol. 273 4 Pt 1 G769 G775
5. M. F. Neurath C. Becker K. Barbulescu 1998 Role of NF-kappaB in immune and inflammatory responses in the gut Gut 43 6 856 860
6. H. Ogata T. Hibi 2003 Cytokine and anti-cytokine therapies for inflammatory bowel disease Curr. Pharm. Des. 9 14 1107 1113
7. C. K. Weber S. Liptay T. Wirth G. Adler R. M. Schmid 2000 Suppression of NF-kappaB activity by sulfasalazine is mediated by direct inhibition of IkappaB kinases alpha and beta Gastroenterology 119 5 1209 1218
8. F. Yan D. B. Polk 1999 Aminosalicylic acid inhibits IkappaB kinase alpha phosphorylation of IkappaBalpha in mouse intestinal epithelial cells J. Biol. Chem. 274 51 36631 36636
9. N. Auphan J. A. DiDonato C. Rosette A. Helmberg M. Karin 1995 Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis Science 270 5234 286 290
10. P. C. Hollman M. N. Bijsman Y. van Gameren E. P. Cnossen J. H. de Vries M. B. Katan 1999 The sugar moiety is a major determinant of the absorption of dietary flavonoid glycosides in man Free Radic. Res. 31 6 569 573
11. V. R. Sinha R. Kumria 2001 Colonic drug delivery: prodrug approach Pharm. Res. 18 5 557 564
12. B. Crotty D. P. Jewell 1992 Drug therapy of ulcerative colitis Br. J. Clin. Pharmacol. 34 3 189 198
13. Y. J. Jung J. S. Lee H. H. Kim Y. M. Kim S. K. Han 1998 Synthesis and evaluation of 5-aminosalicyl-glycine as a potential colon-specific prodrug of 5-aminosalicylic acid Arch. Pharm. Res. 21 2 174 178
14. G. P. Morris P. L. Beck M. S. Herridge W. T. Depew M. R. Szewczuk J. L. Wallace 1989 Hapten-induced model of chronic inflammation and ulceration in the rat colon Gastroenterology 96 3 795 803
15. H. Yano F. Hirayama M. Kamada H. Arima K. Uekama 2002 Colon-specific delivery of prednisolone-appended alpha-cyclodextrin conjugate: alleviation of systemic side effect after oral administration J. Control. Release 79 1-3 103 112
16. M. W. Son J. I. Ko H. M. Doh W. B. Kim T. S. Park M. J. Shim B. K. Kim 1998 Protective effect of taurine on TNBS-induced inflammatory bowel disease in rats Arch. Pharm. Res. 21 5 531 536
17. N. C. Andrews D. V. Faller 1991 A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells Nucleic Acids Res. 19 9 2499
18. R. R. Scheline 1973 Metabolism of foreign compounds by gastrointestinal microorganisms Pharmacol. Rev. 25 4 451 523
19. P. Marteau P. Seksik F. Shanahan 2003 Manipulation of the bacterial flora in inflammatory bowel disease Best Pract. Res., Clin. Gastroenterol. 17 1 47 61
20. J. V. Formica W. Regelson 1995 Review of the biology of quercetin and related bioflavonoids Food Chem. Toxicol. 33 12 1061 1080
21. A. M. Aura K. A. O'Leary G. Williamson M. Ojala M. Bailey R. Puupponen-Pimia A. M. Nuutila K. M. Oksman-Caldentey K. Poutanen 2002 Quercetin derivatives are deconjugated and converted to hydroxyphenylacetic acids but not methylated by human fecal flora in vitro J. Agric. Food Chem. 50 6 1725 1730
22. A. R. Rechner M. A. Smith G. Kuhnle G. R. Gibson E. S. Debnam S. K. Srai K. P. Moore C. A. Rice-Evans 2004 Colonic metabolism of dietary polyphenols: influence of structure on microbial fermentation products Free Radic. Biol. Med. 36 2 212 225
23. L. A. Christensen J. Fallingborg B. A. Jacobsen K. Abildgaard H. H. Rasmussen S. N. Rasmussen S. H. Hansen 1993 Bioavailability of 5-aminosalicyclic acid from slow release 5-aminosalicyclic acid drug and sulfasalazine in normal children Dig. Dis. Sci. 38 10 1831 1836
24. T. Hibi N. Inoue H. Ogata M. Naganuma 2003 Introduction and overview: recent advances in the immunotherapy of inflammatory bowel disease J. Gastroenterol. 38 Suppl. 15 36 42
25. S. W. Kim S. C. Choi E. Y. Choi K. S. Kim J. M. Oh H. J. Lee H. M. Oh S. Kim B. S. Oh K. C. Kimm M. H. Lee G. S. Seo T. H. Kim H. C. Oh W. H. Woo Y. S. Kim H. O. Pae D. S. Park H. T. Chung C. D. Jun 2004 Catalposide, a compound isolated from Catalpa ovata, attenuates induction of intestinal epithelial proinflammatory gene expression and reduces the severity of trinitrobenzene sulfonic acid-induced colitis in mice Inflamm. Bowel Dis. 10 5 564 572
26. P. A. Baeuerle D. Baltimore 1988 I kappa B: a specific inhibitor of the NF-kappa B transcription factor Science 242 4878 540 546
27. C. Kunsch S. M. Ruben C. A. Rosen 1992 Selection of optimal kappa B/Rel DNA-binding motifs: interaction of both subunits of NF-kappa B with DNA is required for transcriptional activation Mol. Cell. Biol. 12 10 4412 4421
28. S. Baba T. Furuta M. Fujioka T. Goromaru 1983 Studies on drug metabolism by use of isotopes: XXVII. Urinary metabolites of rutin in rats and the role of intestinal microflora in the metabolism of rutin J. Pharm. Sci. 72 10 1155 1158
29. P. C. Hollman M. vd Gaag M. J. Mengelers J. M. van Trijp J. H. de Vries M. B. Katan 1996 Absorption and disposition kinetics of the dietary antioxidant quercetin in man Free Radic. Biol. Med. 21 5 703 707
30. T. Walle T. S. Vincent U. K. Walle 2003 Evidence of covalent binding of the dietary flavonoid quercetin to DNA and protein in human intestinal and hepatic cells Biochem. Pharmacol. 65 10 1603 1610
31. T. Cruz J. Galvez M. A. Ocete M. E. Crespo L. H. F. Sanchez de Medina A. Zarzuelo 1998 Oral administration of rutoside can ameliorate inflammatory bowel disease in rats Life Sci. 62 7 687 695
32. S. Y. Zhou D. Fleisher L. H. Pao C. Li B. Winward E. M. Zimmermann 1999 Intestinal metabolism and transport of 5-aminosalicylate Drug Metab. Dispos. 27 4 479 485
33. K. Muraoka K. Shimizu X. Sun T. Tani R. Izumi K. Miwa K. Yamamoto 2002 Flavonoids exert diverse inhibitory effects on the activation of NF-kappaB Transplant. Proc. 34 4 1335 1340
34. S. Y. Cho S. J. Park M. J. Kwon T. S. Jeong S. H. Bok W. Y. Choi W. I. Jeong S. Y. Ryu S. H. Do C. S. Lee J. C. Song K. S. Jeong 2003 Quercetin suppresses proinflammatory cytokines production through MAP kinases and NF-kappaB pathway in lipopolysaccharide-stimulated macrophage Mol. Cell. Biochem. 243 1-2 153 160
35. M. M. Mu D. Chakravortty T. Sugiyama N. Koide K. Takahashi I. Mori T. Yoshida T. Yokochi 2001 The inhibitory action of quercetin on lipopolysaccharide-induced nitric oxide production in RAW 264.7 macrophage cells J. Endotoxin Res. 7 6 431 438
36. A. J. Garcia-Pineres V. Castro G. Mora T. J. Schmidt E. Strunck H. L. Pahl I. Merfort 2001 Cysteine 38 in p65/NF-kappaB plays a crucial role in DNA binding inhibition by sesquiterpene lactones J. Biol. Chem. 276 43 39713 39720
37. F. Sanchez de Medina J. Galvez J. A. Romero A. Zarzuelo 1996 Effect of quercetin on acute and chronic experimental colitis in the rat J. Pharmacol. Exp. Ther. 278 2 771 779